Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Sell
859
-87
-9% -$29.8K 0.14% 77
2026
Q1
$333K Sell
946
-18
-2% -$6.42K 0.18% 75
2025
Q4
$316K Buy
+964
New +$306K 0.15% 77
2024
Q4
$254K Hold
973
0.16% 54
2024
Q3
$314K Sell
973
-36
-4% -$11.8K 0.26% 51
2024
Q2
$315K Sell
1,009
-42
-4% -$12.3K 0.22% 52
2024
Q1
$299K Buy
+1,051
New +$308K 0.27% 46

Other funds holding AMGN

Oxford Wealth Group's AMGN Position: Q2 2026 in Review

Oxford Wealth Group reduced its Amgen (AMGN) stake by 9.2% in Q2 2026, selling an estimated $29.8K and leaving 859 shares worth $311K. The position accounts for 0.14% of the portfolio, ranked #77.

Oxford Wealth Group first reported a position in AMGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $333K in Q1 2026. 3,162 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Oxford Wealth Group held 859 shares of Amgen worth $311K as of Q2 2026.
  • Oxford Wealth Group sold 87 Amgen shares in Q2 2026, an estimated $29.8K.
  • Amgen made up 0.14% of Oxford Wealth Group's portfolio in Q2 2026, its #77 holding.
  • Oxford Wealth Group first reported a position in Amgen in Q1 2024 and has held it in 7 quarters since.
  • Oxford Wealth Group's Amgen position peaked at $333K in Q1 2026.
  • 3,162 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Oxford Wealth Group's 13F filing for Q2 2026, filed 13 Aug 2026.